Wegovy (semaglutide 2.4mg) is FDA-approved for chronic weight management and is increasingly covered by insurance plans, though coverage remains inconsistent. As of 2026, more employers and insurers are adding anti-obesity medication coverage, but Medicare still does not cover weight loss drugs. Wegovy costs approximately

,300 to
,400 per month without insurance.

Key Facts

Wegovy is FDA-approved for weight management in adults with BMI 30+ (or BMI 27+ with at least one weight-related condition)
Approximately 40% of commercial insurance plans now cover Wegovy, up from 25% in 2024
Medicare does not cover Wegovy or any weight loss drugs (federal law prohibits Part D weight loss coverage)
Prior authorization is required by virtually all plans that cover Wegovy
Typical commercial plan copay: $50 to